Warning: The NCBI web site requires JavaScript to function. more...
Treatment of alcohol dependence in patients with co-morbid major depressive disorder--predictors for the outcomes with memantine and escitalopram medication.
Muhonen LH, Lahti J, Sinclair D, Lönnqvist J, Alho H.
Subst Abuse Treat Prev Policy. 2008 Oct 3;3:20.
Related citations
Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence.
Muhonen LH, Lönnqvist J, Juva K, Alho H.
J Clin Psychiatry. 2008 Mar;69(3):392-9.
Age at onset of first depressive episode as a predictor for escitalopram treatment of major depression comorbid with alcohol dependence.
Muhonen LH, Lönnqvist J, Lahti J, Alho H.
Psychiatry Res. 2009 May 15;167(1-2):115-22. Epub 2009 Apr 5.
Serotonin transporter polymorphism as a predictor for escitalopram treatment of major depressive disorder comorbid with alcohol dependence.
Muhonen LH, Lahti J, Alho H, Lönnqvist J, Haukka J, Saarikoski ST.
Psychiatry Res. 2011 Mar 30;186(1):53-7.
Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
Khan A, Bose A, Alexopoulos GS, Gommoll C, Li D, Gandhi C.
Clin Drug Investig. 2007;27(7):481-92.
Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
Kennedy SH, Andersen HF, Lam RW.
J Psychiatry Neurosci. 2006 Mar;31(2):122-31. Erratum in: J Psychiatry Neurosci. 2006 Jul;31(4):228.
Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.
Wade AG, Fernández JL, François C, Hansen K, Danchenko N, Despiegel N.
Pharmacoeconomics. 2008;26(11):969-81.
Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
Clin Ther. 2007 Nov;29(11):2319-32.
Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial.
Kornstein SG, Bose A, Li D, Saikali KG, Gandhi C.
J Clin Psychiatry. 2006 Nov;67(11):1767-75.
Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
Nierenberg AA, Greist JH, Mallinckrodt CH, Prakash A, Sambunaris A, Tollefson GD, Wohlreich MM.
Curr Med Res Opin. 2007 Feb;23(2):401-16.
A pilot double-blind treatment trial of memantine for alcohol dependence.
Evans SM, Levin FR, Brooks DJ, Garawi F.
Alcohol Clin Exp Res. 2007 May;31(5):775-82. Epub 2007 Mar 22.
[Efficacy and tolerability of escitalopram in anxiety disorders: a review].
Pelissolo A.
Encephale. 2008 Sep;34(4):400-8. Epub 2008 Aug 15. Review. French.
Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.
Mao PX, Tang YL, Jiang F, Shu L, Gu X, Li M, Qian M, Ma C, Mitchell PB, Cai ZJ.
Depress Anxiety. 2008;25(1):46-54.
Sertraline treatment of co-occurring alcohol dependence and major depression.
Kranzler HR, Mueller T, Cornelius J, Pettinati HM, Moak D, Martin PR, Anthenelli R, Brower KJ, O'Malley S, Mason BJ, Hasin D, Keller M.
J Clin Psychopharmacol. 2006 Feb;26(1):13-20.
A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder.
Colonna L, Andersen HF, Reines EH.
Curr Med Res Opin. 2005 Oct;21(10):1659-68.
Escitalopram versus venlafaxine XR in the treatment of depression.
Montgomery SA, Andersen HF.
Int Clin Psychopharmacol. 2006 Sep;21(5):297-309.
The influence of baseline severity on efficacy of escitalopram and citalopram in the treatment of major depressive disorder: an extended analysis.
Lam RW, Andersen HF.
Pharmacopsychiatry. 2006 Sep;39(5):180-4.
Double-blind clinical trial of sertraline treatment for alcohol dependence.
Pettinati HM, Volpicelli JR, Luck G, Kranzler HR, Rukstalis MR, Cnaan A.
J Clin Psychopharmacol. 2001 Apr;21(2):143-53.
Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder.
Moore N, Verdoux H, Fantino B.
Int Clin Psychopharmacol. 2005 May;20(3):131-7.
Escitalopram in the treatment of major depressive disorder: a meta-analysis.
Kennedy SH, Andersen HF, Thase ME.
Curr Med Res Opin. 2009 Jan;25(1):161-75.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on